Immunobiology of Dendritic Cells in Cancer

作者: Michael R. Shurin , Anton A. Keskinov , Gurkamal S. Chatta

DOI: 10.1007/978-1-4899-8056-4_5

关键词:

摘要: Dendritic cells (DCs) play a crucial role in initiating immune responses against both foreign pathogens as well tumors. DCs also control the type, potency, and extent of T-cell responses, contribute to natural killer (NK) (NKT cell) antitumoral activity, B-cell-mediated immunity. However, antitumor are often deficient or suboptimal since tumor able exploit functional roles for progression. Suppression, dysfunction, repolarization DC function cancer patients all failure consequent disease Subversion immunity by altering immunoenvironment subset distribution is mediated various malignant cell-derived stroma-derived factors, many which remain be identified. Molecular mechanisms tumor-mediated dysfunction system under investigation, several signaling pathways responsible malfunction have been already described. Here, we summarize findings field biology discuss importance these data designing novel DC-based vaccination strategies, their applicability combinatorial therapeutic approaches.

参考文章(201)
B. J. Nickoloff, G. Burg, F. O. Nestle, T. Wrone-Smith, J. Fäh, Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. American Journal of Pathology. ,vol. 150, pp. 641- 651 ,(1997)
Roswitha M. Wolfram, C. Kichler-Lakomy, Christoph C. Zielinski, Minia Hellan, Thomas Brodowicz, Alexandra C. Budinsky, Chistoph Wiltschke, H. Viernstein, Deficiences in phenotype expression and function of dentritic cells from patients with early breast cancer. European Journal of Medical Research. ,vol. 11, pp. 7- 12 ,(2006)
C. Menetrier-Caux, G. Montmain, M.C. Dieu, C. Bain, M.C. Favrot, C. Caux, J.Y. Blay, Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor Blood. ,vol. 92, pp. 4778- 4791 ,(1998) , 10.1182/BLOOD.V92.12.4778
Dendritic cells in cancer Springer Science + Business Media. ,(2009) , 10.1007/978-0-387-88611-4
Li Yang, David P. Carbone, Tumor-host immune interactions and dendritic cell dysfunction. Advances in Cancer Research. ,vol. 92, pp. 13- 27 ,(2004) , 10.1016/S0065-230X(04)92002-7
Georgi Pirtskhalaishvili, Galina V. Shurin, Michael R. Shurin, Hannah Rabinowich, John M. Kirkwood, Gui-Qiang Wang, Clemens Esche, Tumor Necrosis Factor-α-promoted Expression of Bcl-2 and Inhibition of Mitochondrial Cytochrome c Release Mediate Resistance of Mature Dendritic Cells to Melanoma-induced Apoptosis Clinical Cancer Research. ,vol. 7, ,(2001)
Georgi Pirtskhalaishvili, Galina V. Shurin, Andrea Gambotto, Clemens Esche, Madeline Wahl, Zoya R. Yurkovetsky, Paul D. Robbins, Michael R. Shurin, Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice. Journal of Immunology. ,vol. 165, pp. 1956- 1964 ,(2000) , 10.4049/JIMMUNOL.165.4.1956
Irina L. Tourkova, Galina V. Shurin, Gurkamal S. Chatta, Lori Perez, James Finke, Theresa L. Whiteside, Soldano Ferrone, Michael R. Shurin, Restoration by IL-15 of MHC Class I Antigen-Processing Machinery in Human Dendritic Cells Inhibited by Tumor-Derived Gangliosides The Journal of Immunology. ,vol. 175, pp. 3045- 3052 ,(2005) , 10.4049/JIMMUNOL.175.5.3045
Roch Houot, Ivan Perrot, Eric Garcia, Isabelle Durand, Serge Lebecque, Human CD4+CD25high Regulatory T Cells Modulate Myeloid but Not Plasmacytoid Dendritic Cells Activation Journal of Immunology. ,vol. 176, pp. 5293- 5298 ,(2006) , 10.4049/JIMMUNOL.176.9.5293